Comparison of Selected Parameters of Redox Homeostasis in Patients with Ataxia-Telangiectasia and Nijmegen Breakage Syndrome.

Journal: Oxidative medicine and cellular longevity
PMID:

Abstract

This study compared the antioxidant status and major lipophilic antioxidants in patients with ataxia-telangiectasia (AT) and Nijmegen breakage syndrome (NBS). Total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), and concentrations of coenzyme Q10 (CoQ10) and vitamins A and E were estimated in the plasma of 22 patients with AT, 12 children with NBS, and the healthy controls. In AT patients, TAS (median 261.7 mol/L) was statistically lower but TOS (496.8 mol/L) was significantly elevated in comparison with the healthy group (312.7 mol/L and 311.2 mol/L, resp.). Tocopherol (0.8 g/mL) and CoQ10 (0.1 g/mL) were reduced in AT patients versus control (1.4 g/mL and 0.3 g/mL, resp.). NBS patients also displayed statistically lower TAS levels (290.3 mol/L), while TOS (404.8 mol/L) was comparable to the controls. We found that in NBS patients retinol concentration (0.1 g/mL) was highly elevated and CoQ10 (0.1 g/mL) was significantly lower in comparison with those in the healthy group. Our study confirms disturbances in redox homeostasis in AT and NBS patients and indicates a need for diagnosing oxidative stress in those cases as a potential disease biomarker. Decreased CoQ10 concentration found in NBS and AT indicates a need for possible supplementation.

Authors

  • Barbara Pietrucha
    Clinical Immunology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-730 Warsaw, Poland.
  • Edyta Heropolitanska-Pliszka
    Clinical Immunology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-730 Warsaw, Poland.
  • Mateusz Maciejczyk
    Department of Experimental Pharmacology, Medical University of Bialystok, Szpitalna 37 Str., 15-295 Bialystok, Poland.
  • Halina Car
    Department of Experimental Pharmacology, Medical University of Bialystok, Szpitalna 37 Str., 15-295 Bialystok, Poland.
  • Jolanta Sawicka-Powierza
    Department of Family Medicine, Medical University of Bialystok, Bialystok, Poland.
  • Radosław Motkowski
    Department of Pediatrics Rheumatology, Immunology, and Metabolic Bone Diseases, Medical University of Bialystok, Waszyngtona 17 Str., 15-274 Bialystok, Poland.
  • Joanna Karpinska
    Institute of Chemistry, University of Bialystok, Bialystok, Poland.
  • Marta Hryniewicka
    Institute of Chemistry, University of Bialystok, Bialystok, Poland.
  • Anna Zalewska
    Department of Conservative Dentistry, Medical University of Bialystok, Bialystok, Poland.
  • Malgorzata Pac
    Clinical Immunology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-730 Warsaw, Poland.
  • Beata Wolska-Kusnierz
    Clinical Immunology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-730 Warsaw, Poland.
  • Ewa Bernatowska
    Clinical Immunology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-730 Warsaw, Poland.
  • Bozena Mikoluc
    Department of Pediatrics Rheumatology, Immunology, and Metabolic Bone Diseases, Medical University of Bialystok, Waszyngtona 17 Str., 15-274 Bialystok, Poland.